A Dose Escalation Study of Radio-labeled Antibody for the Treatment of Advanced Cancer

NCT02454010 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

BIOLOGICAL: FF21101

Sponsor

Fujifilm Pharmaceuticals U.S.A., Inc.